These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8977543)
1. Reduction of the central nervous system adverse effects associated with antihistamines in the management of allergic disorders: strategies and progress. Gengo FM J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 3):S319-25. PubMed ID: 8977543 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of H1-antihistamines: an update. Kalpaklioglu F; Baccioglu A Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):230-7. PubMed ID: 23173575 [TBL] [Abstract][Full Text] [Related]
4. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects. Kaliner MA Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437 [TBL] [Abstract][Full Text] [Related]
5. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Golightly LK; Greos LS Drugs; 2005; 65(3):341-84. PubMed ID: 15669879 [TBL] [Abstract][Full Text] [Related]
6. H1-antihistamines and the central nervous system. Welch MJ; Meltzer EO; Simons FE Clin Allergy Immunol; 2002; 17():337-88. PubMed ID: 12113223 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects. Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304 [TBL] [Abstract][Full Text] [Related]
8. Molecular pharmacology of second-generation antihistamines. Grant JA Allergy Asthma Proc; 2000; 21(3):135-40. PubMed ID: 10892514 [TBL] [Abstract][Full Text] [Related]
9. Safety considerations in the management of allergic diseases: focus on antihistamines. Yanai K; Rogala B; Chugh K; Paraskakis E; Pampura AN; Boev R Curr Med Res Opin; 2012 Apr; 28(4):623-42. PubMed ID: 22455874 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study. Ferrer M; Morais-Almeida M; Guizova M; Khanferyan R Clin Drug Investig; 2010; 30(1):15-34. PubMed ID: 19995095 [TBL] [Abstract][Full Text] [Related]
17. Histamine and H1-antihistamines: celebrating a century of progress. Simons FE; Simons KJ J Allergy Clin Immunol; 2011 Dec; 128(6):1139-1150.e4. PubMed ID: 22035879 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis. Spangler DL; Brunton S South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414 [TBL] [Abstract][Full Text] [Related]
19. Advances in H1-antihistamines. Simons FE N Engl J Med; 2004 Nov; 351(21):2203-17. PubMed ID: 15548781 [No Abstract] [Full Text] [Related]
20. Cetirizine: a unique second-generation antihistamine for treatment of rhinitis and chronic urticaria. Pierson WE Clin Ther; 1991; 13(1):92-9. PubMed ID: 1674232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]